Validate wearable assessment of walking
- Trial ID
- NCT05874739
- Official Title
- Validating a Digital Mobility Assessment in Parkinson's Disease Using Wearable Technology - the Mobilise-D Extension Study.
- Goal
- Validate wearable assessment of walking
- Status
- RECRUITING
- Sponsor
- Newcastle-upon-Tyne Hospitals NHS Trust
- Study Type
- OBSERVATIONAL
- Enrollment
- 651 participants
- Conditions
- Parkinson Disease, Aging
Plain-Language Summary
Mobilise-D's extension aims to validate a digital mobility assessment, to see if wearable sensors can reliably capture everyday walking and balance changes in people with Parkinson's and in older adults. Participants wear a small sensor that records steps, gait speed, stride length, turning and activity patterns in real life, so researchers can compare those objective measures with clinical ratings and track mobility over time. The study is looking for two groups: older control volunteers aged 50 and over who can walk 4 meters unaided and are willing to wear a sensor for about 12 months, and people with Parkinson's already enrolled in the Mobilise-D clinical validation cohort, aged 18 and over with Hoehn and Yahr stages I to III. People with recent major cardiac events, active cancer, dementia, or other neurological or orthopedic conditions that significantly affect walking are excluded.
Locations
- The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying an experimental treatment. Mobilise-D's extension aims to validate a digital mobility assessment, to see if wearable sensors can reliably capture everyday walking and balance changes in people with Parkinson's and in older adults. Participants wear a small sensor that records steps, gait speed, stride length, turning and activity patterns in real life, so researchers can compare those objective measures with clinical ratings and track mobility over time. The study is looking for two groups: older control volunteers aged 50 and over who can walk 4 meters unaided and are willing to wear a sensor for about 12 months, and people with Parkinson's already enrolled in the Mobilise-D clinical validation cohort, aged 18 and over with Hoehn and Yahr stages I to III. People with recent major cardiac events, active cancer, dementia, or other neurological or orthopedic conditions that significantly affect walking are excluded.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 2 years and 2 months.